DK1978944T3 - Blød-gelatine-kapselformulering - Google Patents

Blød-gelatine-kapselformulering

Info

Publication number
DK1978944T3
DK1978944T3 DK07707560.4T DK07707560T DK1978944T3 DK 1978944 T3 DK1978944 T3 DK 1978944T3 DK 07707560 T DK07707560 T DK 07707560T DK 1978944 T3 DK1978944 T3 DK 1978944T3
Authority
DK
Denmark
Prior art keywords
soft gelatin
capsule formulation
capsule
formulation
gelatin
Prior art date
Application number
DK07707560.4T
Other languages
English (en)
Inventor
Yukiko Hashitera
Ryuji Ueno
Ryu Hirata
Yasuhiro Harada
Original Assignee
Sucampo Ag
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38169220&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1978944(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo Ag, R Tech Ueno Ltd filed Critical Sucampo Ag
Application granted granted Critical
Publication of DK1978944T3 publication Critical patent/DK1978944T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK07707560.4T 2006-01-24 2007-01-23 Blød-gelatine-kapselformulering DK1978944T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76136006P 2006-01-24 2006-01-24
PCT/JP2007/051329 WO2007086536A2 (en) 2006-01-24 2007-01-23 Soft-gelatin capsule formulation

Publications (1)

Publication Number Publication Date
DK1978944T3 true DK1978944T3 (da) 2012-11-05

Family

ID=38169220

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07707560.4T DK1978944T3 (da) 2006-01-24 2007-01-23 Blød-gelatine-kapselformulering

Country Status (16)

Country Link
US (4) US8026393B2 (da)
EP (1) EP1978944B1 (da)
JP (1) JP4783794B2 (da)
KR (1) KR101393944B1 (da)
CN (3) CN104983712A (da)
AU (1) AU2007208632B2 (da)
BR (1) BRPI0707334B8 (da)
CA (1) CA2637274C (da)
DK (1) DK1978944T3 (da)
ES (1) ES2392590T3 (da)
IL (1) IL192867A (da)
MX (1) MX2008009650A (da)
NZ (1) NZ570191A (da)
PT (1) PT1978944E (da)
RU (1) RU2420291C3 (da)
WO (1) WO2007086536A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104983712A (zh) * 2006-01-24 2015-10-21 株式会社·R-技术上野 软明胶胶囊制剂
CN101808623B (zh) * 2007-07-19 2013-08-14 株式会社·R-技术上野 包含11-脱氧-前列腺素化合物的药物组合物和使该化合物稳定化的方法
JP4879351B2 (ja) † 2007-10-19 2012-02-22 大塚製薬株式会社 医薬固形製剤
US20110071163A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
WO2011054087A1 (en) 2009-11-03 2011-05-12 Bernard Charles Sherman Stable pharmaceutical formulations comprising lubiprostone
JP2014515004A (ja) * 2011-04-27 2014-06-26 スキャンポ・アーゲー イオン輸送体の調節方法
MA37469A1 (fr) 2012-04-30 2016-04-29 Dow Agrosciences Llc Véhicules d'administration d'une composition de pesticide
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
CA2980165C (en) 2015-03-26 2021-06-15 Patheon Softgels Inc. Liquisoft capsules
KR20180058758A (ko) 2015-09-22 2018-06-01 그레이버그 비젼, 인크. 안구 장애의 치료를 위한 화합물 및 조성물
CN107638403B (zh) * 2016-07-22 2020-05-05 江苏威凯尔医药科技有限公司 一种硬胶囊制剂
US11534404B2 (en) 2016-10-06 2022-12-27 Sucampo Ag Multilayer beads for pharmaceutical use
GB201711157D0 (en) * 2017-07-11 2017-08-23 Univ Liverpool Sulfur-Doped Carbonaceous porous materials
CN108619107A (zh) * 2018-05-28 2018-10-09 青海制药厂有限公司 一种含鲁比前列酮的软胶囊及其制备方法
JP7678698B2 (ja) * 2020-04-21 2025-05-16 東和薬品株式会社 ルビプロストンを含む軟カプセル剤及びその製造方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656877A5 (de) * 1981-11-27 1986-07-31 Erba Farmitalia Optisch aktive oder racemische prostaglandinderivate.
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5591887A (en) 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
ATE120647T1 (de) 1987-05-28 1995-04-15 Hiroshi Maeda Superoxid-dismutase-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel.
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
US5048022A (en) * 1989-08-01 1991-09-10 Digital Equipment Corporation Memory device with transfer of ECC signals on time division multiplexed bidirectional lines
CA2022372C (en) 1989-08-09 2000-05-02 Ryuji Ueno Improvement of excretion of nonprotein nitrogen into the intestine by prostanoic acid derivatives
US5254588A (en) 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
JPH07100655B2 (ja) * 1990-04-04 1995-11-01 株式会社アールテック・ウエノ 白内障処置剤
TW249226B (da) 1990-04-04 1995-06-11 Aderk Ueno Kk
DE69130586T2 (de) 1990-05-01 1999-06-17 R-Tech Ueno, Ltd., Osaka Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
JPH04187637A (ja) * 1990-11-21 1992-07-06 Ueno Seiyaku Oyo Kenkyusho:Kk 記憶改善剤
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
KR19990036322A (ko) 1996-06-10 1999-05-25 류지 우에노 엔도텔린길항제
US5998438A (en) * 1996-11-26 1999-12-07 Allelix Biopharmaceuticals, Inc. 5-cyclo indole compounds
US6207699B1 (en) * 1999-06-18 2001-03-27 Richard Brian Rothman Pharmaceutical combinations for treating obesity and food craving
ATE402925T2 (de) 1999-10-15 2008-08-15 Sucampo Ag Neue zusammensetzung enthaltend eine bicyclische verbindung und ein glycerid
CZ20032256A3 (en) * 2001-02-22 2004-03-17 Ono Pharmaceutical Co., Ltd. Medicinal compositions comprising diclofenac and ornoprostil
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
CN104983712A (zh) * 2006-01-24 2015-10-21 株式会社·R-技术上野 软明胶胶囊制剂
BRPI0707333B8 (pt) * 2006-01-24 2021-05-25 R Tech Ueno Ltd composição farmacêutica que compreende um composto bicíclico, método de estabilização do composto bicíclico e formulação de cápsula de gelatina mole
CN101808623B (zh) * 2007-07-19 2013-08-14 株式会社·R-技术上野 包含11-脱氧-前列腺素化合物的药物组合物和使该化合物稳定化的方法

Also Published As

Publication number Publication date
US8779187B2 (en) 2014-07-15
NZ570191A (en) 2010-09-30
AU2007208632A1 (en) 2007-08-02
CN104983712A (zh) 2015-10-21
CN104971056A (zh) 2015-10-14
RU2420291C3 (ru) 2020-07-21
US20140287036A1 (en) 2014-09-25
WO2007086536A2 (en) 2007-08-02
KR20080090526A (ko) 2008-10-08
JP4783794B2 (ja) 2011-09-28
US20070172523A1 (en) 2007-07-26
MX2008009650A (es) 2008-11-06
AU2007208632B2 (en) 2012-01-19
IL192867A0 (en) 2009-02-11
KR101393944B1 (ko) 2014-05-12
US20130078303A1 (en) 2013-03-28
US8338639B2 (en) 2012-12-25
CA2637274A1 (en) 2007-08-02
US20110300211A1 (en) 2011-12-08
EP1978944A2 (en) 2008-10-15
IL192867A (en) 2015-06-30
US8026393B2 (en) 2011-09-27
RU2420291C2 (ru) 2011-06-10
ES2392590T3 (es) 2012-12-12
JP2008534432A (ja) 2008-08-28
RU2008134489A (ru) 2010-02-27
PT1978944E (pt) 2012-11-26
CN101410097A (zh) 2009-04-15
WO2007086536A3 (en) 2007-11-15
BRPI0707334A2 (pt) 2011-05-03
EP1978944B1 (en) 2012-08-15
BRPI0707334A8 (pt) 2018-04-10
BRPI0707334B1 (pt) 2021-02-23
CA2637274C (en) 2013-06-04
BRPI0707334B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
BRPI0716325A2 (pt) Composição antimicrobianas
ATE443753T1 (de) Nuancierungsmittel
DE602006019782D1 (de) Kapselperforationsmodul
DE602007009650D1 (de) Spiroindolinonderivate
AT504580A3 (de) Scan-einrichtung
DE602007003893D1 (de) Kippambossanordnung
DE602007006947D1 (de) Pyridopyrimidinonderivate
DE602007000258D1 (de) Kassetteneinspannmechanismus
DE602007009337D1 (de) Tastfeedbackvorrichtung
DE602007001280D1 (de) Getränkeextraktor
DK1849352T3 (da) Mejetærsker
DE602007008400D1 (de) Kaliummonopersulfatlösungen
DE602007010359D1 (de) Azaspiroderivate
DE602007001098D1 (de) Spindelmäheinheit
DE602006020192D1 (de) Riemenscheibenanorndung
DE502007001629D1 (de) Rfahren
EP2043136A4 (en) FILMING COMPOSITION
BRPI0717939A2 (pt) Aminometil-4-imidazóis
FR2899479B1 (fr) Composition cicatrisante
DE602007000501D1 (de) Breitbandrichtkoppler
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE602007010544D1 (de) Motorstatorstruktur
DE602007004080D1 (de) Tintenstrahlaufnehmer
DE602007007460D1 (de) Sehkrafttestsystem
DE502007000361D1 (de) Stanznieteinheit